CoChat

Green biologics: The algal chloroplast as a platform for making biopharmaceuticals

Open access
Taunt, Henry N., Stoffels, Laura, Purton, Saul · 2018 · Bioengineered

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Most commercial production of recombinant pharmaceutical proteins involves the use of mammalian cell lines, E. coli or yeast as the expression host. However, recent work has demonstrated the potential of eukaryotic microalgae as platforms for light-driven synthesis of such proteins. Expression in the algal chloroplast is particularly attractive since this organelle contains a minimal genome suitable for rapid engineering using synthetic biology approaches; with transgenes precisely targeted to specific genomic loci and amenable to high-level, regulated and stable expression. Furthermore, proteins can be tightly contained and bio-encapsulated in the chloroplast allowing accumulation of proteins otherwise toxic to the host, and opening up possibilities for low-cost, oral delivery of biologics. In this commentary we illustrate the technology with recent examples of hormones, protein antibiotics and immunotoxins successfully produced in the algal chloroplast, and highlight possible future applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21655979.2017.1377867

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. A low-cost, single-use photobioreactor system for commercial production of algal biomass. This ‘hanging bag’ system was developed by the Cawthron Institute, New Zealand for production of microalgae as aquaculture feed and for cultivation of Haematococcus pluvialis – a natural source of the high-value nutraceutical astaxanthin. We have successfully adapted the system for endolysin and vaccine production in C. reinhardtii (L. Stoffels, B. Parker and S. Purton, submitted). The 40 litre bags are optimally illuminated and sterile 5% CO2/95% air supplied at the base of each bag for phototrophic growth and for mixing. Both batch and continuous operation is possible. ©Supreme Health, New Zealand. Reproduced by permission of Supreme Health, New Zealand. Permission to reuse must be obtained from the rightsholder.
Figure 1. A low-cost, single-use photobioreactor system for commercial production of algal biomass. This ‘hanging bag’ system was developed by the Cawthron Institute, New Zealand for production of microalgae as aquaculture feed and for cultivation of Haematococcus pluvialis – a natural source of the high-value nutraceutical astaxanthin. We have successfully adapted the system for endolysin and vaccine production in C. reinhardtii (L. Stoffels, B. Parker and S. Purton, submitted). The 40 litre bags are optimally illuminated and sterile 5% CO2/95% air supplied at the base of each bag for phototrophic growth and for mixing. Both batch and continuous operation is possible. ©Supreme Health, New Zealand. Reproduced by permission of Supreme Health, New Zealand. Permission to reuse must be obtained from the rightsholder.CC BY · PubMed Central
Figure 2. The chloroplast genome of Chlamydomonas reinhardtii. Generated from Genbank entry BK000554 using OGDRAW (ogdraw.mpimp-golm.mpg.de). Genes are coloured according to function (e.g. photosystem II genes in dark green), with genes transcribed anticlockwise on the outer side of the circle; those transcribed clockwise on the inner side. Examples of verified neutral sites for transgene insertion are indicated by arrowheads, with those within the inverted repeat (IR) regions that therefore give rise to two transgene copies per genome shown in light or dark blue.
Figure 2. The chloroplast genome of Chlamydomonas reinhardtii. Generated from Genbank entry BK000554 using OGDRAW (ogdraw.mpimp-golm.mpg.de). Genes are coloured according to function (e.g. photosystem II genes in dark green), with genes transcribed anticlockwise on the outer side of the circle; those transcribed clockwise on the inner side. Examples of verified neutral sites for transgene insertion are indicated by arrowheads, with those within the inverted repeat (IR) regions that therefore give rise to two transgene copies per genome shown in light or dark blue.CC BY · PubMed Central
Figure 3. A synbio strategy for creating marker-free transgenic lines that also incorporate a biocontainment feature. Standardised DNA parts are assembled in order using Golden Gate to create the transgene device, with left (L) and right (R) flanking plastome elements (shown as bold lines) added for homologous recombination in the chloroplast. One element carries a wild-type copy of an essential photosynthetic (p/s) gene allowing phototrophic selection in the recipient chassis that lacks this gene. The synthetic gene-of-interest is codon-optimised and fused to promoter and untranslated region (UTR) parts. Biocontainment can be incorporated into the transgene by replacing one or more tryptophan codons with the UGA stop codon (*), thereby preventing function transfer of the gene to other microorganisms. Correct translation in the chloroplast is achieved by inclusion of a part carrying trnWUCA. This gene encodes an orthogonal variant of the chloroplast's tryptophan tRNA that recognises UGA.
Figure 3. A synbio strategy for creating marker-free transgenic lines that also incorporate a biocontainment feature. Standardised DNA parts are assembled in order using Golden Gate to create the transgene device, with left (L) and right (R) flanking plastome elements (shown as bold lines) added for homologous recombination in the chloroplast. One element carries a wild-type copy of an essential photosynthetic (p/s) gene allowing phototrophic selection in the recipient chassis that lacks this gene. The synthetic gene-of-interest is codon-optimised and fused to promoter and untranslated region (UTR) parts. Biocontainment can be incorporated into the transgene by replacing one or more tryptophan codons with the UGA stop codon (*), thereby preventing function transfer of the gene to other microorganisms. Correct translation in the chloroplast is achieved by inclusion of a part carrying trnWUCA. This gene encodes an orthogonal variant of the chloroplast's tryptophan tRNA that recognises UGA.CC BY · PubMed Central
Figure 4. Illustration of a designer immunotoxin produced in the C. reinhardtii chloroplast showing the multi-domain structure. The human CD22-scFv domain was fused to the hinge and constant domains of a human IgG1 and to exotoxin A from Pseudomonas aeruginosa lacking domain 1a. This created an immunotoxin that formed a homodimer through disulphide bonds between the hinge regions. Redrawn from12.
Figure 4. Illustration of a designer immunotoxin produced in the C. reinhardtii chloroplast showing the multi-domain structure. The human CD22-scFv domain was fused to the hinge and constant domains of a human IgG1 and to exotoxin A from Pseudomonas aeruginosa lacking domain 1a. This created an immunotoxin that formed a homodimer through disulphide bonds between the hinge regions. Redrawn from12.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 81

Metadata

Authors
Taunt, H. N., Stoffels, L., & Purton, S.
Affiliations
  • Algenuity, Eden Laboratory, Stewartby, United Kingdom
  • Institute of Structural and Molecular Biology (GB)
Corresponding author
Purton, Saul
Venue
Bioengineered
Published
2017-09-29
Volume
9
Issue
1
Pages
48-54
ISSN
  • 2165-5979 (ISSN-L)
  • 2165-5987
OpenAlex
W2754622169
Cited by
81
References
36
Citations by year
2026: 6 · 2025: 1 · 2024: 13 · 2023: 12 · 2022: 11 · 2021: 15 · 2020: 8 · 2019: 10 · 2018: 4 · 2017: 1
Type
journal article
Language
en
Open access
Locations
  • Bioengineered (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Biotechnology and Biological Sciences Research Council (BB/F016948/1, BB/L002957/1, BB/L013789/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
  • Physical Sciences › Energy › Renewable Energy, Sustainability and the Environment › Algal biology and biofuel production
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
Keywords
recombinant protein expression, microalgae, biopharmaceuticals, chloroplast transformation, synthetic biology, protein encapsulation, oral drug delivery, immunotoxins, plant hormones
MeSH terms
Chlorophyta, Anti-Bacterial Agents, Immunotoxins, Biological Products, Chloroplasts, Genetic Engineering, Genetic Vectors, Recombinant Proteins, Transformation, Genetic, Gene Expression, Chlamydomonas reinhardtii, Transgenes, Human Growth Hormone, Dietary Supplements, Genome, Chloroplast, Microalgae, Synthetic Biology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Green biologics: The algal chloroplast as a platform for making biopharmaceuticals. https://app.cochat.ai/papers/10.1080/21655979.2017.1377867
The paper
Taunt, H. N., Stoffels, L., & Purton, S. (2018). Green biologics: The algal chloroplast as a platform for making biopharmaceuticals. Bioengineered. https://doi.org/10.1080/21655979.2017.1377867

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.